4XT-27808-30653 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-02
Dose 1 — Pfizer-BioNTech
2021-04-23
Dose 2 — Pfizer-BioNTech
2021-04-27
Registered in v-safe
2021-04-27
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy — Feeling: Good · Headache, Fatigue or tiredness

Free text: swollen axilla area

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-28
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache, Fatigue or tiredness

Adult check-in
2021-05-07
Survey response — day 14, dose 2
MedDRA: Pregnancy — Feeling: Good

Free text: pregnancy

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-30
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-07-23
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-02	Pfizer-BioNTech
2	2021-04-23	Pfizer-BioNTech

Free text

Release 8 — days 1–6 daily, dose 2

2021-04-27

Systemic reaction (other): swollen axilla area

Release 8 — day 14, dose 2

2021-05-07

Symptoms: pregnancy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Pregnancy	✓	✓	✓
SRO	Lymphadenopathy	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release